Regarding the method validation for the parameter Microbiological quality for finished drug products - are there recommendations/common practices regarding the number of batches/repetitions for performing the method validation?
Ivana Jovanovska – Klincharska
MSc of Biological Sciences
Stability, In Silico Toxicology, Microbiology
Research & Development
ALKALOID AD Skopje
Republic of Macedonia
tel: +389 2 3104 134
mob: +389 70 276542
e-mail: [log in to unmask]
The PMFList (http://microbiologynetwork.com/pmflist.asp) is operated from
The Microbiology Network (http://microbiologynetwork.com) and supported by
our sponsors as a service to the scientific community.
Please take a second to visit our sponsors' web sites and say thank you for their support of this service.
Accuratus Lab Services http://www.accuratuslabs.com/
Associates of Cape Cod, Inc. - http://www.acciusa.com/
Nelson Labs - http://www.nelsonlabs.com
BD Diagnostic Systems - http://www.bd.com/ds/
Biolog - http://www.biolog.com
Analytical Research Labs - http://arlok.com/
Charles River-Endosafe and Accugenix - http://www.criver.com/emd
Microbiologics, Inc. - http://www.microbiologics.com
Steris - http://www.sterislifesciences.com/
Veltek Associates, Inc - http://www.sterile.com
The nature of this service is to provide a medium for communication. The specific statements and endorsements of individuals participating in the discussions are not necessarily those of The Microbiology Network, Inc., the PMF, or the sponsors of the list.